Attempt to remove party from proceedings fails
This unusual application in Teva Pharma BV & Anor v Amgen Inc & Anor  EWHC 3711 (Pat) related to proceedings to revoke a European patent and a declaration that a supplementary protection certificate (SPC) based upon it (for lipegfilgrastim) would not be valid. The proceedings were issued against the company listed as proprietor on the patents register (D1), even though that company had assigned the patent (without the claimant knowing) to a related company (D2) a few weeks earlier. D1 and D2 subsequently applied for an order that D1 should cease to be a party to proceedings commenced by the claimant.
The claimant believed that D1 had damaging documents in its possession and that the motive for the assignment had been a tactical one to avoid D1 having to give disclosure. The court had to decide whether it was ‘desirable’ within the meaning of CPR 19.2(3) for D1 to cease to be a party…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world